In short. The Q-switched 1064 nm laser is a nanosecond-pulsed near-infrared laser used for dermal pigment and dark tattoo ink. Its long wavelength is absorbed far less by epidermal melanin than 532 nm, so energy reaches the dermis with little competition from surrounding skin, making it first-line on Asian and darker skin. It does not treat redness, vascular lesions, or texture.
Key points
- Long wavelength bypasses most epidermal melanin and reaches dermal pigment.
- Indications include nevus of Ota, acquired bilateral nevus of Ota-like macules, deep sun pigment and dark ink.
- Low-fluence toning can rarely cause mottling; unstable melasma needs review first.
- Five to ten sessions, six to eight weeks apart; maintenance is rarely needed.
- It does not treat redness, vascular lesions or surface texture.
1064 nm or 532 nm?
| 1064 nm | 532 nm | |
|---|---|---|
| Absorption in epidermal melanin | Much less | Strong |
| Depth reached | Dermis | Superficial skin |
| Main targets | Dermal pigment and black or dark blue tattoo ink | Superficial brown spots |
| Asian and darker skin | Standard first-line, with test spots | Higher pigment risk, use with caution |
| Main caution | Rebound pigment if pushed too hard | Competition from the skin's own melanin |
Shorter wavelengths such as 532 nm are absorbed strongly by epidermal melanin. That makes them useful for superficial brown spots but risky on darker skin. At 1064 nm, absorption by epidermal melanin is much lower, so the energy reaches the dermal pigment or tattoo ink with less competition from the surrounding skin. This is the safety foundation that makes the device a workhorse for Asian and darker skin types.
What does the Q-switched 1064 nm laser treat, and what does it not?
The 1064 nm Q-switched laser is used for dermal pigment such as nevus of Ota, acquired bilateral nevus of Ota-like macules, deep sun-induced pigment, and dark tattoo lines in black and dark blue. It is also used in low-fluence laser toning protocols for diffuse pigment. Toning is used with caution because overtreatment can rarely cause mottling. The wavelength does not treat redness, vascular lesions, or texture.
How a session runs
After skin-type assessment, the clinician treats the area with a focused Q-switched beam. The sensation is brief and sharp; topical numbing is routine. Treated pigment darkens briefly, then fades over weeks. Most plans involve five to ten sessions, spaced six to eight weeks apart. Maintenance is rarely needed once clearance is stable.
Is it safe on Asian and darker skin?
For melanin-rich skin, the 1064 nm Q-switched wavelength is the standard first-line choice for dermal pigment and dark tattoo ink. Conservative parameters, longer intervals, strict sun protection, and test spots on inconspicuous areas are routine. The goal is clearance, not speed. Pushing harder risks rebound pigment and rarely improves the outcome.
What is recovery like?
Mild redness and swelling settle within hours. Treated pigment may darken briefly before clearing over weeks. Strict broad-spectrum sun protection, gentle barrier-supportive skincare, and avoidance of irritants for several days are the standard routine. Pigment-control topicals can resume once the skin has fully calmed.
Risks and limits
Common temporary effects are redness, mild swelling, and brief pinpoint bleeding or whitening at higher settings. Less common effects include post-inflammatory hyperpigmentation, hypopigmentation, and rarely mottling after repeated low-fluence toning. Tattoo clearance depends on ink colour, depth, and density. Realistic discussion of clearance, the number of sessions needed, and the possibility of incomplete removal is part of safe practice.
When should treatment be deferred or reviewed?
- An active tan, recent sunburn, or photosensitising medication: treatment should be deferred.
- Active melasma or unstable pigment: Q-switched toning protocols can worsen mottling and need careful review.
- Persistent pain, blistering, or unusual pigment change after a session: early review can limit long-lasting colour shift.
Sources
- American Academy of Dermatology: laser and energy device information
- American Society for Laser Medicine and Surgery: laser safety by skin type
- Cochrane Library: reviews of laser and light treatments for pigmentation
Internal links
Frequently asked questions
Why is the 1064 nm wavelength preferred on darker skin?
It is absorbed much less by epidermal melanin, so the energy reaches dermal pigment or tattoo ink with less competition from the surrounding skin. That is the safety foundation which makes it a workhorse for Asian and darker skin types.
What does this wavelength treat, and what does it not?
It is used for dermal pigment such as nevus of Ota, acquired bilateral nevus of Ota-like macules, deep sun-induced pigment and dark tattoo lines, and in low-fluence toning protocols. It does not treat redness, vascular lesions or surface texture.
What is the risk of laser toning protocols?
Low-fluence toning is used with caution because repeated treatment can rarely cause mottling. The goal is clearance rather than speed. Pushing harder risks rebound pigment and rarely improves the outcome, and unstable or active melasma needs review before any toning.
Risks & Limitations
- Burns and blistering if settings do not match the skin.
- Post-inflammatory hyperpigmentation, particularly in darker skin types, which may take months to settle.
- Hypopigmentation (lightening) of treated skin, which can be permanent.
- Scarring, including hypertrophic scarring, which is uncommon but real.
- Infection, including reactivation of herpes simplex after resurfacing.
- Acne or milia flare during recovery.
- Results are incremental and most concerns need several sessions. Melasma may rebound or worsen with aggressive treatment.
When to Seek Care
- Blistering, weeping or broken skin beyond the expected reaction.
- Severe pain that is worsening rather than settling.
- Spreading redness, warmth, pus or fever.
- New darkening or firmness that looks like scarring at the treated area.
- Any change in a treated pigmented lesion — it should be reviewed, not retreated.
References & Further Reading
- American Academy of Dermatology (AAD) — laser and energy device information
- American Society for Laser Medicine & Surgery (ASLMS)
- National Medical Products Administration (NMPA, China) — device registration status
- Cochrane Library — systematic reviews in laser dermatology
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.